Rapiblyk 87073-0110-01

Generic: Landiolol

Package NDC

87073-0110-01

Manufacturer: Aop Health Us, Llc
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 19, 2025
Listing Expires: December 31, 2027
Application: NDA217202

Need to source Rapiblyk? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Landiolol Hydrochloride	280 mg/1

Drug Class

Adrenergic beta1-Antagonists [MoA]beta-Adrenergic Blocker [EPC]

Selected Package

87073-0110-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (87073-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE